Protagenic Therapeutics, Inc. (PTIX)
OTCMKTS · Delayed Price · Currency is USD
0.81638
-0.04362 (-5.07%)
At close: Sep 24, 2026
Protagenic Therapeutics Market Cap
Protagenic Therapeutics has a market cap or net worth of $1.48 million as of September 25, 2026. Its market cap has decreased by -82.26% in one year.
Market Cap
1.48M
Enterprise Value
911.83K
Revenue
n/a
Ranking
n/a
PE Ratio
0.28
Stock Price
$0.82
ChartMarket Cap Chart
Since May 19, 2025, Protagenic Therapeutics's market cap has decreased from 9.64M to 1.48M, a decrease of -84.67%. That is a compound annual growth rate of -75.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 1.48M | -41.25% |
| Dec 31, 2025 | 2.52M | -73.91% |
| May 19, 2025 | 9.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bioxytran | 2.31M |
| VitaSpring Biomedical | 2.30M |
| Nymox Pharmaceutical | 2.10M |
| AccuStem Sciences | 1.88M |
| Avenue Therapeutics | 1.57M |
| Enzolytics | 1.45M |
| Helix BioMedix | 1.35M |
| inTerra Resources | 1.30M |